Thomas B. Okarma
Chief Tech/Sci/R&D Officer at Rejuvenan Global Health, Inc.
Profile
Thomas B.
Okarma was the founder of Applied Immune Sciences, Inc. founded in 1985, where he held the title of Chairman & Chief Executive Officer in 1995.
Currently, he is a Director at Biotechnology Innovation Organization, Rejuvenan Global Health, Inc., and Geron Bio-Med Ltd.
In the past, he served as President, Chief Executive Officer & Director at Geron Corp.
from 1998 to 2011, and as President, Chief Executive Officer & Director at Asterias Biotherapeutics, Inc. from 2012 to 2014.
He also held the position of Senior Vice President at Rhone-Poulenc Rorer, Inc. in 1995 and Vice President at Cell Therapies Pty Ltd.
in 1997-1998.
Dr. Okarma received his undergraduate degree from Dartmouth College and his doctorate from Stanford University.
Thomas B. Okarma active positions
Companies | Position | Start |
---|---|---|
Geron Bio-Med Ltd. | Director/Board Member | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Rejuvenan Global Health, Inc.
Rejuvenan Global Health, Inc. Medical/Nursing ServicesHealth Services Rejuvenan Global Health, Inc. engages in the provision of wellness programs and telemedicine consultations. It offers personalized coaching and other interactive tools that drive behavioral change through the adoption of healthy lifestyle. The company was founded by Fred Nazem and Rishi Madhok and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Former positions of Thomas B. Okarma
Companies | Position | End |
---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 09/04/2014 |
GERON CORPORATION | President | 07/02/2011 |
Cell Therapies Pty Ltd. | Corporate Officer/Principal | 30/04/1998 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | 30/11/1996 |
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Founder | 31/12/1994 |
Training of Thomas B. Okarma
Dartmouth College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GERON CORPORATION | Health Technology |
Private companies | 7 |
---|---|
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Rejuvenan Global Health, Inc.
Rejuvenan Global Health, Inc. Medical/Nursing ServicesHealth Services Rejuvenan Global Health, Inc. engages in the provision of wellness programs and telemedicine consultations. It offers personalized coaching and other interactive tools that drive behavioral change through the adoption of healthy lifestyle. The company was founded by Fred Nazem and Rishi Madhok and is headquartered in New York, NY. | Health Services |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Geron Bio-Med Ltd. | |
Cell Therapies Pty Ltd. |
- Stock Market
- Insiders
- Thomas B. Okarma